Seasonal variation and environmental predictors of exhaled nitric oxide in children with asthma

Pediatric Pulmonology

Volumn 43, Issue 6, 2008, Pages 576-583

  Spanier, Adam J ^a,b   Hornung, Richard W ^a   Kahn, Robert S ^a   Lierl, Michelle B ^a   Lanphear, Bruce P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b MLC 7035 ^*  (United States)

Author keywords

Allergen; Inhaled corticosteroid; Sensitization; Tobacco smoke

Indexed keywords

ALLERGEN; BIOLOGICAL MARKER; CIGARETTE SMOKE; CORTICOSTEROID; HOUSE DUST ALLERGEN; NITRIC OXIDE;

ADOLESCENT; AIRBORNE PARTICLE; ALLERGY; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXPIRED AIR; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL VARIATION; SENSITIZATION;

ADMINISTRATION, INHALATION; AIR POLLUTION, INDOOR; ALLERGENS; ANIMALS; ANIMALS, DOMESTIC; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BREATH TESTS; CATS; CHILD; COCKROACHES; COHORT STUDIES; DOGS; DRUG UTILIZATION; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE; PROSPECTIVE STUDIES; SEASONS; STEROIDS; TOBACCO SMOKE POLLUTION;

EID: 44949177495     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20816     Document Type: Article

References (48)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 2002;51:1-13.
2. O'Connell EJ. The burden of atopy and asthma in children. Allergy 2004;59:7-11.
3. Akinbami L. The state of childhood asthma, United States, 1980-2005. Adv Data 2006;381:1-24.
4. Leone FT, Mauger EA, Peters SP, Chinchilli VM, Fish JE, Boushey HA, Cherniack RM, Drazen JM, Fahy JV, Ford J, Israel E, Lazarus SC, Lemanske RF, Martin RJ, McGeady SJ, Sorkness C, Szefler SJ. The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research. Chest 2001;119:1027-1033.
5. Apter AJ, ZuWallack RL, Clive J. Common measures of asthma severity lack association for describing its clinical course. J Allergy Clin Immunol 1994;94:732-737.
6. Zacharasiewicz A, Erin EM, Bush A. Noninvasive monitoring of airway inflammation and steroid reduction in children with asthma. Curr Opin Allergy Clin Immunol 2006;6:155-160.
7. Kwok MY, Walsh-Kelly CM, Gorelick MH, Grabowski L, Kelly KJ. National Asthma Education and Prevention Program severity classification as a measure of disease burden in children with acute asthma. Pediatrics 2006;117:S71-S77.
8. Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN, Adams GK III, Mitchell HE. Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med 2006;160:844-850.
9. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368-1370.
10. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003;142:469-475.
11. Lanz MJ, Leung DY, White CW. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Ann Allergy Asthma Immunol 1999;82:161-164.
12. Moeller A, Franklin P, Hall GL, Turner S, Straub D, Wildhaber JH, Stick SM. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrent wheezy infants. Pediatr Pulmonol 2004; 38:250-255.
13. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-1019.
14. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
15. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R III, Stout J, Malindzak G, Smartt E, Plaut M, Walter M, Vaughn B, Mitchell H. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004;351:1068-1080.
16. Franklin PJ, Turner SW, Le Souef PN, Stick SM. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 2003;58:1048-1052.
17. Simpson A, Custovic A, Pipis S, Adisesh A, Faragher B, Woodcock A. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am J Respir Crit Care Med 1999;160:45-49.
18. Roberts G, Hurley C, Bush A, Lack G. Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax 2004;59:752-756.
19. Verleden GM, Dupont LJ, Verpeut AC, Demedts MG. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest 1999;116:59-64.
20. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609-612.
21. Barreto M, Villa MP, Martella S, Ronchetti F, Darder MT, Falasca C, Pagani J, Massa F, Ronchetti R. Exhaled nitric oxide in asthmatic and non-asthmatic children: influence of type of allergen sensitization and exposure to tobacco smoke. Pediatr Allergy Immunol 2001;12:247-256.
22. Yates DH, Breen H, Thomas PS. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am J Respir Crit Care Med 2001;164:1043-1046.
23. Johnston NW, Sears MR. Asthma exacerbations. 1: epidemiology. Thorax 2006;61:722-728.
24. Koenig JQ, Jansen K, Mar TF, Lumley T, Kaufman J, Trenga CA, Sullivan J, Liu LJ, Shapiro GG, Larson TV. Measurement of offline exhaled nitric oxide in a study of community exposure to air pollution. Environ Health Perspect 2003;111:1625-1629.
25. Spanier AJ, Hornung R, Lierl M, Lanphear BP. Environmental exposures and exhaled nitric oxide in children with asthma. J Pediatr 2006;149:220-226.
26. Wilson SE, Kahn RS, Khoury J, Lanphear BP. Racial differences in exposure to environmental tobacco smoke among children. Environ Health Perspect 2005;113:362-367.
27. Baraldi E, de Jongste JC. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002;20:223-237.
28. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160: 2104-2117.
29. Sievers Nitric Oxide Analyzer (NOA) 280i Homepage. Cited 2007 November 1; Available from http://www.ionicsinstruments. com/ionics/index.cfm?product_code= NitricOxideAnalyzer& category_code=NOA.
30. Lanphear BP, Emond M, Jacobs DE, Weitzman M, Tanner M, Winter NL, Yakir B, Eberly S. A side-by-side comparison of dust collection methods for sampling lead-contaminated house dust. Environ Res 1995;68:114-123.
31. Chapman MD, Aalberse RC, Brown MJ, Platts-Mills TA. Monoclonal antibodies to the major feline allergen Fel d I. II. Single step affinity purification of Fel d I, N-terminal sequence analysis, and development of a sensitive two-site immunoassay to assess Fel d I exposure. J Immunol 1988;140:812-818.
32. Pollart SM, Smith TF, Morris EC, Gelber LE, Platts-Mills TA, Chapman MD. Environmental exposure to cockroach allergens: analysis with monoclonal antibody-based enzyme immunoassays. J Allergy Clin Immunol 1991;87:505-510.
33. Luczynska CM, Arruda LK, Platts-Mills TA, Miller JD, Lopez M, Chapman MD. A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods 1989;118:227-235.
34. Ewan PW, Coote D. Evaluation of a capsulated hydrophilic carrier polymer (the ImmunoCAP) for measurement of specific IgE antibodies. Allergy 1990;45:22-29.
35. Bernert JT, Jr., Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, Ann Q, Covey TR, Whitfield WE, Gunter EW, Miller BB, Patterson DG, Jr., Needham LL, Hannon WH, Sampson EJ. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997;43:2281-2291.
36. Eliopoulos C, Klein J, Koren G. Validation of self-reported smoking by analysis of hair for nicotine and cotinine. Ther Drug Monit 1996;18:532-536.
37. Bernert JT, Jr., McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol 2000; 24:333-339.
38. Hammond SK, Sorensen G, Youngstrom R, Ockene JK. Occupational exposure to environmental tobacco smoke. JAMA 1995;274:956-960.
39. Marbury MC, Hammond SK, Haley NJ. Measuring exposure to environmental tobacco smoke in studies of acute health effects. Am J Epidemiol 1993;137:1089-1097.
40. Eisner MD, Katz PP, Yelin EH, Hammond SK, Blanc PD. Measurement of environmental tobacco smoke exposure among adults with asthma. Environ Health Perspect 2001;109:809-814.
41. de Gouw HW, Grunberg K, Schot R, Kroes AC, Dick EC, Sterk PJ. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998;11:126-132.
42. van Strien RT, Koopman LP, Kerkhof M, Spithoven J, de Jongste JC, Gerritsen J, Neijens HJ, Aalberse RC, Smit HA, Brunekreef B. Mite and pet allergen levels in homes of children born to allergic and nonallergic parents: the PIAMA study. Environ Health Perspect 2002;110:A693-698.
43. Langley SJ, Goldthorpe S, Craven M, Morris J, Woodcock A, Custovic A. Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol 2003; 112:362-368.
44. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004;114:1241-1256.
45. Dinakar C, Lapuente M, Barnes C, Garg U. Real-life environmental tobacco exposure does not affect exhaled nitric oxide levels in asthmatic children. J Asthma 2005;42:113-118.
46. Mannino DM, Moorman JE, Kingsley B, Rose D, Repace J. Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2001;155:36-41.
47. Heinrich J, Holscher B, Douwes J, Richter K, Koch A, Bischof W, Fahlbusch B, Kinne RW, Wichmann HE. Reproducibility of allergen, endotoxin and fungi measurements in the indoor environment. J Expo Anal Environ Epidemiol 2003;13:152-160.
48. Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, Carlisle DM, Mangione CM, Kahn KL. What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 2006;44:132-140.